A Ludwig Cancer Research study has developed a novel nanotechnology that triggers potent therapeutic anti-tumor immune responses and demonstrated its efficacy in mouse models of multiple cancers. Led by Co-director Ralph Weichselbaum, investigator Wenbin Lin and postdoctoral researcher Kaiting Yang at the Ludwig Center at Chicago, the study describes the synthesis, mechanism of action and preclinical assessment of the nanoparticle, which is loaded with a drug that activates a protein central to the efficient induction of anti-cancer immunity.
Lire la suiteThe rapid increase in the world’s population has subsequently increased the demand for food supply. Farmers often lose their agricultural produce due to pathogenic infestations, poor soil conditions, water, and environmental factors. Scientists believe nanobiosensors can play a crucial role in revolutionizing the farming system by determining threats to prevent agricultural loss.
Lire la suite